Bayer HealthCare / Press

Once-Daily Xarelto® from Bayer Effective and Well-Tolerated Alternative to Vitamin K Antagonists in Protecting Patients with Atrial Fibrillation who Undergo Cardioversion

These data were presented today during the Hot Line Session at the ESC Congress 2014, and published simultaneously in the European Heart Journal. more      

In Focus

Healthcare News

Photos & Videos

  • Photos

    Photo galleries with topic-related images.

  • TV Footage

    In this section you can find videos for editorial coverage.

Bayer HealthCare Links

Annual report Integrated Annual Report of Bayer AG 2013
RSS Feed
RSS Feed

Copyright © Bayer HealthCare AG